Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Profit After Tax: 2010-2024

Historic Profit After Tax for Kura Oncology (KURA) over the last 14 years, with Dec 2024 value amounting to -$174.0 million.

  • Kura Oncology's Profit After Tax fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$216.9 million, marking a year-over-year change of. This contributed to the annual value of -$174.0 million for FY2024, which is 13.99% down from last year.
  • Per Kura Oncology's latest filing, its Profit After Tax stood at -$174.0 million for FY2024, which was down 13.99% from -$152.6 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Profit After Tax registered a high of -$89.6 million during FY2020, and its lowest value of -$174.0 million during FY2024.
  • For the 3-year period, Kura Oncology's Profit After Tax averaged around -$154.2 million, with its median value being -$152.6 million (2023).
  • Data for Kura Oncology's Profit After Tax shows a maximum YoY slumped of 45.57% (in 2021) over the last 5 years.
  • Kura Oncology's Profit After Tax (Yearly) stood at -$89.6 million in 2020, then slumped by 45.57% to -$130.5 million in 2021, then decreased by 4.12% to -$135.8 million in 2022, then declined by 12.36% to -$152.6 million in 2023, then decreased by 13.99% to -$174.0 million in 2024.